|Peer Reviewer||Representation||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|John Harold||Official ACC (BOT)||None||None||None||None||None|
|Dhanunjaya Lakkireddy||Official ACC (BOG)||None||None||None||None||None|
|Richard L. Prager||Official STS||None||None||None||None||None||None|
|Graham Nichol||Official AHA||None||None||None||None|
|Randal J. Thomas||Content AHA GWTG Steering Committee||None||None||None||None||None||None|
|Martha Radford||Content NCDR Management Board||None||None||None||None||None||None|
|Debra Ness||Content: National Partnership for Women and Families||None||None||None||None||None||None|
|Frederic Resnic||Content: NCDR Science and Quality Oversight Committee||None||None||None||None|
This table represents the relationships of reviewers with industry and other entities that were disclosed at the time of peer review and determined to be relevant. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document.
ACC indicates American College of Cardiology; AED, automated external defibrillator; AHA, American Heart Association; BOG, Board of Governors; BOT, Board of Trustees; Co-I, co-investigator; FDA, Food and Drug Administration; GWTG, Get With The Guidelines; NCDR, National Cardiovascular Data Registry; NHLBI, National Heart, Lung, and Blood Institute; PI, principal investigator; STS, The Society of Thoracic Surgeons.